JianPiYiShen Formula Prevents Cisplatin-induced Acute Kidney Injury in Mice by Improving Necroptosis Through MAPK Pathway

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2024 Feb 24

PMID 38402163

Authors

Zhongtang Li

Riming He

Jiahui Liu

Xiaoming Jin

Beibei Jiang

Yunlan Lao

Shudong Yang

Affiliations

Soon will be listed here.

Abstract

Background: Acute kidney injury (AKI), characterized by necroptosis and activation of MAPK pathway, causes sudden declines in renal function. To date, efficacious treatments are lacking. JianPiYiShen Formula (JPYSF) has a protective effect on the kidneys. The aim of this study is to explore the mechanism of JPYSF in cisplatin-induced AKI.

Methods: Male C57/BL6J mice were divided into control group, cisplatin group and cisplatin + JPYSF group. Before establishing the model, the cisplatin + JPYSF group was administered JPYSF (18.35 g/kg/day) by gavage for 5 consecutive days. A single intraperitoneal injection of cisplatin (20 mg/kg) was used to establish AKI model. Measurement of renal function and H&E staining were performed to assess renal damage. WB, PCR, TUNEL staining and immunohistochemistry were used to detect related indicators of mitochondrial function, oxidative stress, necroptosis, inflammation and MAPK pathway. And one-way analysis of variance was used to compare group differences.

Results: Compared with the cisplatin group, JPYSF can attenuate AKI, reflected by the decrease in Scr and BUN levels, the improvement of renal tubular injury, and the downregulation of NGAL and KIM1. Cisplatin can induce mitochondrial dysfunction and oxidative stress, triggering necroptosis. In this study, JPYSF improved mitochondrial dysfunction to enhance oxidative stress, as manifested by upregulation of OPA1, PGC-1α, SOD and CAT, and downregulation of DRP1 and MFF. Then JPYSF showed a significant protective effect in necroptosis, as embodied by reduced number of TUNEL-positive cells, decreased the gene expression of RIPK3 and MLKL, as well as downregulation the proteins expression of P-RIPK1, P-RIPK3, and P-MLKL. Moreover, necroptosis can aggravate inflammation. JPYSF ameliorated inflammation by improving inflammatory and anti-inflammatory indexes, including downregulation of TNF-α, IL-6, MCP-1 and LY6G, and upregulation of IL-10. In addition, JPYSF also inhibited MAPK pathway to improve necroptosis by decreasing the expression of P-JNK and P-ERK.

Conclusion: Our data showed that JPYSF prevents cisplatin-induced AKI by improving necroptosis through MAPK pathway, which is related to the improvement of mitochondrial dysfunction, oxidative stress, and inflammation.

References

Zhao Y, Li X, Wang F, Huang S, Du H, Li S . Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial-Mesenchymal Transition. Front Pharmacol. 2022; 13:873023. PMC: 9152215. DOI: 10.3389/fphar.2022.873023. View

McSweeney K, Kate Gadanec L, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V . Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers (Basel). 2021; 13(7). PMC: 8036620. DOI: 10.3390/cancers13071572. View

Lu Q, Wang M, Gui Y, Hou Q, Gu M, Liang Y . Rheb1 protects against cisplatin-induced tubular cell death and acute kidney injury via maintaining mitochondrial homeostasis. Cell Death Dis. 2020; 11(5):364. PMC: 7221100. DOI: 10.1038/s41419-020-2539-4. View

Manohar S, Leung N . Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2017; 31(1):15-25. DOI: 10.1007/s40620-017-0392-z. View

Fang C, Lou D, Zhou L, Wang J, Yang B, He Q . Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021; 42(12):1951-1969. PMC: 8633358. DOI: 10.1038/s41401-021-00620-9. View

Alassaf N, Attia H . Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential. Front Pharmacol. 2023; 14:1103062. PMC: 9922871. DOI: 10.3389/fphar.2023.1103062. View

Chen X, Wei W, Li Y, Huang J, Ci X . Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact. 2019; 308:269-278. DOI: 10.1016/j.cbi.2019.05.040. View

Zhang W, Zheng X, Gong Y, Jiang T, Qiu J, Wu X . VX-11e protects articular cartilage and subchondral bone in osteoarthritis by inhibiting the RIP1/RIP3/MLKL and MAPK signaling pathways. Bioorg Chem. 2022; 120:105632. DOI: 10.1016/j.bioorg.2022.105632. View

Almaghrabi O . Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi J Biol Sci. 2015; 22(2):227-31. PMC: 4336453. DOI: 10.1016/j.sjbs.2014.12.008. View

10.

Liu X, Xie X, Ren Y, Shao Z, Zhang N, Li L . The role of necroptosis in disease and treatment. MedComm (2020). 2022; 2(4):730-755. PMC: 8706757. DOI: 10.1002/mco2.108. View

11.

Wu Y, Yang B . Erythropoietin Receptor/β Common Receptor: A Shining Light on Acute Kidney Injury Induced by Ischemia-Reperfusion. Front Immunol. 2021; 12:697796. PMC: 8278521. DOI: 10.3389/fimmu.2021.697796. View

12.

Shen D, Guo M, Geng X, Yu J, Zhang Z, Lin J . Magnesium Lithospermate B Protects Against Cisplatin-Induced Acute Kidney Injury via Alleviating Mitochondrial Dysfunction. Drug Des Devel Ther. 2022; 16:2293-2304. PMC: 9296868. DOI: 10.2147/DDDT.S358830. View

13.

Wu W, Wang X, Yu X, Lan H . Smad3 Signatures in Renal Inflammation and Fibrosis. Int J Biol Sci. 2022; 18(7):2795-2806. PMC: 9066101. DOI: 10.7150/ijbs.71595. View

14.

Miao Z, Miao Z, Shi X, Wu H, Yao Y, Xu S . The antagonistic effect of selenium on lead-induced apoptosis and necroptosis via P38/JNK/ERK pathway in chicken kidney. Ecotoxicol Environ Saf. 2022; 231:113176. DOI: 10.1016/j.ecoenv.2022.113176. View

15.

Kim J, Kim K, Son J, Kim H, Park J, Lee S . Protective Effects of against Cisplatin-Induced Nephrotoxicity without Altering Chemotherapeutic Efficacy. Antioxidants (Basel). 2019; 8(8). PMC: 6721194. DOI: 10.3390/antiox8080256. View

16.

Zhou M, Dai Y, Ma Y, Yan Y, Hua M, Gao Q . Protective Effects of Liquiritigenin against Cisplatin-Induced Nephrotoxicity via NRF2/SIRT3-Mediated Improvement of Mitochondrial Function. Molecules. 2022; 27(12). PMC: 9231399. DOI: 10.3390/molecules27123823. View

17.

Zhang Y, Su S, Zhao S, Yang Z, Zhong C, Chen X . RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun. 2017; 8:14329. PMC: 5309790. DOI: 10.1038/ncomms14329. View

18.

Zhao X, Shi X, Liu Q, Li X . Tea polyphenols alleviates acetochlor-induced apoptosis and necroptosis via ROS/MAPK/NF-κB signaling in Ctenopharyngodon idellus kidney cells. Aquat Toxicol. 2022; 246:106153. DOI: 10.1016/j.aquatox.2022.106153. View

19.

Hu W, Wu X, Yu D, Zhao L, Zhu X, Li X . Regulation of JNK signaling pathway and RIPK3/AIF in necroptosis-mediated global cerebral ischemia/reperfusion injury in rats. Exp Neurol. 2020; 331:113374. DOI: 10.1016/j.expneurol.2020.113374. View

20.

Al Shahrani M, Chandramoorthy H, Alshahrani M, Abohassan M, Eid R, Ravichandran K . Cassia auriculata leaf extract ameliorates diabetic nephropathy by attenuating autophagic necroptosis via RIP-1/RIP-3-p-p38MAPK signaling. J Food Biochem. 2021; 45(7):e13810. DOI: 10.1111/jfbc.13810. View